Advertisement
U.S. markets close in 3 hours 40 minutes
  • S&P 500

    5,252.21
    +3.72 (+0.07%)
     
  • Dow 30

    39,784.90
    +24.82 (+0.06%)
     
  • Nasdaq

    16,387.95
    -11.57 (-0.07%)
     
  • Russell 2000

    2,134.00
    +19.65 (+0.93%)
     
  • Crude Oil

    82.53
    +1.18 (+1.45%)
     
  • Gold

    2,234.60
    +21.90 (+0.99%)
     
  • Silver

    24.86
    +0.11 (+0.46%)
     
  • EUR/USD

    1.0800
    -0.0029 (-0.27%)
     
  • 10-Yr Bond

    4.1850
    -0.0110 (-0.26%)
     
  • GBP/USD

    1.2635
    -0.0003 (-0.03%)
     
  • USD/JPY

    151.2870
    +0.0410 (+0.03%)
     
  • Bitcoin USD

    70,840.29
    +2,093.27 (+3.04%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,964.73
    +32.75 (+0.41%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Today's Research Reports on Trending Tickers: Arena Pharmaceuticals Inc. and GW Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / July 11, 2017 / A rally by technology stocks helped lift U.S. markets Monday. While the S&P 500 Index's Technology sector has fallen approximately 3 percent from its high set on June 8th, the sector is still leading the way for the S&P 500 Index with a gain of approximately 18 percent year-to-date. The Dow Jones Industrial Average declined 0.03 percent to close at 21,408.52, while the S&P 500 Index gained 0.09 percent to close at 2,427.43. The tech-heavy NASDAQ Composite Index gained 0.38 percent to close at 6,176.39, up roughly 14.74 percent year-to-date.

"All of the conversations right now are about earnings," said Mike Antonelli, equity sales trader at Robert W Baird & Co. "The health-care bill and the tax bill all of that has been put on the back burner as the market moves on to the next catalyst, and what matters right now is earnings," added Antonelli.

RDI Initiates Coverage on:

Arena Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=ARNA

GW Pharmaceuticals
https://ub.rdinvesting.com/news/?ticker=GWPH

Arena Pharmaceuticals Inc.'s stock moved 4.47% lower Monday, to close the day at $18.39. The stock recorded a trading volume of 2,533,743 shares, which was above its three months average volume of 345,650 shares. In the last year, Arena Pharmaceuticals Inc.'s shares have traded in a range of 11.30 - 19.90. The share price has gained 62.74% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $13.76 is below its 200-day moving average of $14.27. Shares of Arena Pharmaceuticals have gained approximately 29.51 percent year-to-date.

Access RDI's Arena Pharmaceuticals Research Report at:
https://ub.rdinvesting.com/news/?ticker=ARNA

On Monday, shares in GW Pharmaceuticals recorded a trading volume of 325,114 shares, which was above the three months average volume of 262,073 shares. The stock ended the day 1.94% lower at 100.10. The share price has gained 25.73% from its 52 week low with a 52 week trading range of 79.62 - 137.88.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $101.55 is below its 200-day moving average of $115.09. Shares of GW Pharmaceuticals have fallen approximately 10.43 percent year-to-date.

Access RDI's GW Pharmaceuticals Research Report at:
https://ub.rdinvesting.com/news/?ticker=GWPH

Our Actionable Research on Arena Pharmaceuticals Inc. (NASDAQ: ARNA) and GW Pharmaceuticals (NASDAQ: GWPH) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

Advertisement